The Greenshoots Podcast by Appleyard Lees gives listeners access to insights from leading intellectual property specialists.
The bi-weekly programme delivers practical, timely guidance to innovators, inventors and IP owners and managers.
Leading IP specialists discuss the most important topics in patents, trade marks, IP litigation and IP strategy, in real time.
Episode one features patent attorneys Adam Tindall, an engineer, and Richard Bray, a physicist, discussing IPO responses to COVID-19, navigating uncertainty in IP, new (and old) ways of working, sector-specific impacts, resurrecting…
Cambridge, UK, 07 May 2020: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Inotrem, a specialist in immunotherapy for acute and chronic inflammatory syndromes. As part of the agreement, IONTAS will apply its Mammalian Display technology to identify antibodies involved in the TREM-1 pathway.
TREM-1, an immunoreceptor expressed on innate immune cells, has been identified by Inotrem as a key therapeutic target for many acute or chronic inflammation syndromes, including sepsis and…
AMSBIO has extended its COVID-19 research portfolio with the introduction of a service to provide custom lentivirus pseudotyped with spike glycoprotein from SARS-CoV-2 to help researchers identify potential targets for development of therapeutic drugs and vaccines. Various research groups around the world have demonstrated that SARS-CoV-2 uses its spike glycoprotein S, a main target for neutralization antibody, to bind its receptor, and mediate membrane fusion and virus entry.In response to widespread demand, AMSBIO has developed a custom service to provide ready-to-use in…
In response to the COVID-19 outbreak, A4P Bio Logistics has collaborated with Wren Healthcare to offer a one-stop solution for CROs, sponsors, and study sites to support the continuation of clinical trial studies through home nursing and direct-to-patient IMP and sample logistics. It has become increasingly difficult for patients to attend study sites, and our homecare solution allows studies to continue by taking the trial to the patient.
email tim.davies@a4pbio.com to find out how we can support through home nursing and our network of DTP logistic services.
Cambridge and Inverness, UK, 30th April 2020: TTP plc (TTP), a leading independent technology and product development company, has announced today that it has partnered with ODx (ODx Innovations Ltd), a company committed to developing a system for assessing urinary tract infections (UTIs). The collaboration is focussed on bringing ODx’ system to market through TTP’s Desktop Biology service.
The ODx system offers the potential to revolutionise the turnaround time for the assessment of suspected UTIs, reduce the use of antibiotics and provider faster access to optimal antimicrobial therapy.…
Cambridge, UK, 29 April 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced it has added two new sample formats to its cell-based OncoSpan reference standards for use in the development and validation of workflows for cancer diagnostic assays.
Horizon’s OncoSpan range now includes formalin-fixed, paraffin-embedded (FFPE) and cell-free DNA (cfDNA) formats for mimicking solid tumors and liquid biopsy samples, respectively, in addition to its well-…
Cambridge, UK: In vitro fertilisation (IVF) treatment is now a global affair which involves patients, fertility clinics, embryologists and transportation specialists. Each country has different legislation relating to fertility treatments, and with many patients now finding themselves seeking IVF in a country which supports their specific needs, it is crucial to securely and reliably transport the invaluable frozen eggs, sperms or embryos from one fertility clinic to another for further treatment cycles.
A patient was looking for a specialist courier to manage the transportation of frozen…
One Nucleus adds power and influence as senior AstraZeneca executive, Penny James joins the region’s life science membership organisation’s Board
Cambridge, UK: 28 April 2020: One Nucleus, the Cambridge based not-for-profit membership organisation for the East of England-London life sciences cluster, is delighted to announce the appointment of Penny James as a Non-Executive Director. Penny is Chief Operating Officer, Biopharmaceuticals R&D at AstraZeneca, a role she took up in February 2019.
Penny has 25 years’ experience working in pharmaceutical and chemical industries, having…
Cambridge, 27th April 2020: The Babraham Research Campus is delighted to confirm Eisai as the latest high-profile organisation to provide financial and mentoring support for its Accelerate@Babraham initiative. The additional funding will further enhance the ability of the Babraham Research Campus to drive innovation in early science concepts and nurture new life science companies within the Cambridge cluster.
First launched in 2018, the Accelerate@Babraham initiative supports ambitious early stage life science ventures by giving access to appropriate short-term open access laboratory and…